Literature DB >> 16932839

[Innovative imaging in urology: fascination and future. Yesterday, today, and tomorrow].

T Loch1, G Schneider.   

Abstract

In contrast to other countries (e.g., USA) the German urologist routinely utilizes imaging in order to evaluate urological disorders. Ultrasound as a basic tool has acquired importance similar to the physical examination or the patient history. Because of its minimal invasiveness and low cost, it is increasingly utilized as a first-line exam.In correlation with the patient history and laboratory data more invasive imaging studies are performed and in unclear cases or in the preoperative work-up more extensive imaging procedures like computed tomography (CT) or magnetic resonance imaging (MRI) are utilized. Even in emergency situations the urologist is able to guide interventions under ultrasound or conventional X-ray guidance (e.g., percutaneous drainage of dilated kidney), which resulted in a much lower complication rate of the various procedures. In those cases in which ultrasound is technically infeasible or in unclear cases CT and MRI are used as problem-solving procedures and are able to give the correct diagnosis in a large percentage of cases.After a brief historical overview, newer modalities and innovative techniques are explored and presented. Assuming that these innovative approaches lead to more accurate diagnosis and staging of various neoplastic and nonneoplastic conditions, treatment can be performed in earlier stages of diseases and better stage-adapted treatment can be offered to the patients.

Entities:  

Mesh:

Year:  2006        PMID: 16932839     DOI: 10.1007/s00120-006-1135-2

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  46 in total

1.  High-resolution multidetector CT in the preoperative evaluation of patients with renal cell carcinoma.

Authors:  C Catalano; F Fraioli; A Laghi; A Napoli; F Pediconi; M Danti; P Nardis; R Passariello
Journal:  AJR Am J Roentgenol       Date:  2003-05       Impact factor: 3.959

2.  [CT in ureterolithiasis with a radiation dose equal to intravenous urography: results in 209 patients].

Authors:  E Knöpfle; M Hamm; S Wartenberg; K Bohndorf
Journal:  Rofo       Date:  2003-12

Review 3.  [New techniques in computed tomography. Significance for urology].

Authors:  J Stattaus; M Forsting; M Goyen
Journal:  Urologe A       Date:  2004-11       Impact factor: 0.639

4.  Suspected ureteral colic: primary helical CT versus selective helical CT after unenhanced radiography and sonography.

Authors:  Orlando Catalano; Antonio Nunziata; Francesco Altei; Alfredo Siani
Journal:  AJR Am J Roentgenol       Date:  2002-02       Impact factor: 3.959

5.  Breath-hold R2* mapping with a multiple gradient-recalled echo sequence: application to the evaluation of intrarenal oxygenation.

Authors:  P V Prasad; Q Chen; J W Goldfarb; F H Epstein; R R Edelman
Journal:  J Magn Reson Imaging       Date:  1997 Nov-Dec       Impact factor: 4.813

6.  [Ultrasound in urology (author's transl)].

Authors:  H Watanabe
Journal:  Rinsho Byori       Date:  1979-09

Review 7.  [Ultrasonic diagnosis in urology].

Authors:  H Heynemann
Journal:  Z Urol Nephrol       Date:  1980-01

8.  Preoperative staging of renal cell carcinoma with inferior vena cava thrombus using multidetector CT and MRI: prospective study with histopathological correlation.

Authors:  Peter J Hallscheidt; Christian Fink; Axel Haferkamp; Michael Bock; Ante Luburic; Ivan Zuna; Gerd Noeldge; Guenter Kauffmann
Journal:  J Comput Assist Tomogr       Date:  2005 Jan-Feb       Impact factor: 1.826

9.  [Computerized supported transrectal ultrasound (C-TRUS) in the diagnosis of prostate cancer].

Authors:  T Loch
Journal:  Urologe A       Date:  2004-11       Impact factor: 0.639

10.  Measurement of single-kidney glomerular filtration rate using a contrast-enhanced dynamic gradient-echo sequence and the Rutland-Patlak plot technique.

Authors:  Nils Hackstein; Jan Heckrodt; Wigbert S Rau
Journal:  J Magn Reson Imaging       Date:  2003-12       Impact factor: 4.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.